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This report summarizes the spread of a raccoon rabies epizootic into New York in the 1990s, the species
of animals affected, and human postexposure treatments (PET). A total of 57,008 specimens were submit-
ted to the state laboratory from 1993 to 1998; 8,858 (16%) animals were confirmed rabid, with raccoons
the most common species (75%). After exposure to 11,769 animals, 18,238 (45%) persons received PET,
mostly because of contact with saliva or nervous tissue. We analyzed expenditure reports to estimate the
cost of rabies prevention activities. An estimated $13.9 million was spent in New York State to prevent
rabies from 1993 to 1998. Traditional prevention methods such as vaccinating pets, avoiding wildlife, and
verifying an animal’s rabies status must be continued to reduce costly PET. To reduce rabid animals, expo-
sures, and costs, oral vaccination of wildlife should also be considered.
he incidence of human rabies is high in developing coun-
tries, and most cases of the illness occur in humans with
untreated dog bites (1,2). In developing countries, rabies con-
trol in domestic canids has shifted the source of rabies expo-
sures for most humans and domestic animals to wild terrestrial
animals. Reported animal rabies cases in the United States
have increased dramatically since 1990 in association with the
raccoon rabies epizootic in the mid-Atlantic and northeastern
states. Before 1990, rabies infections in New York were attrib-
uted to red fox and bat variants of the virus. After 1993, rabies
testing indicated that the red fox variant no longer existed in
the state (3); instead, a raccoon rabies variant had moved into
New York State from Pennsylvania in 1990. 
Nationwide, the number of reported rabies cases in ani-
mals increased from 6,972 in 1991 to 9,495 in 1993, but
decreased to 8,224 in 1994, 8,509 in 1997, and 7,961 in 1998
(4–11). Wild animals accounted for 92% of animal rabies
cases in the United States, with raccoons reported most fre-
quently, followed by skunks, bats, and foxes. The number of
human cases remained low in the same time period, ranging
from one case in 1998 to six cases in 1994 (4–11). In 1991,
New York State accounted for 14% of reported rabid animals
in the United States; this proportion increased to 28% in 1993
(12,13). 
The exposure of humans and domestic animals to rabid
animals has resulted in an estimated 16,000–39,000 persons
per year receiving postexposure prophylaxis treatment (PET)
in the United States (14). The estimated cost for human post-
exposure treatment ranges from $1,039 to $4,447 per person
(15). Including pet animal vaccinations, the total cost of treat-
ment was recently estimated at $300 million per year in the
United States (16). 
New York State has passed a legislative appropriation for
rabies prevention and PET. Reimbursement of PET costs not
covered by third-party payers was first established more than
50 years ago in response to concerns about potential human
deaths from fox rabies in those who could not afford treatment.
Since the New York State Department of Health (NYSDOH)
disburses these funds, this agency can provide accurate esti-
mates of the cost of postexposure rabies treatments in the state.
In addition, NYSDOH’s active rabies laboratory conducts all
diagnostic work in the state, excluding New York City, which
has its own laboratory (although test result data from New
York City are also reported).
Initial analyses of rabies treatments for four New York
counties in 1993 and 1994 have been previously published
(13). In this study, we examine the reemergence of rabies in
New York and summarize information on the spread of rabid
animals, the type of animals involved, trends in human expo-
sures to rabid animals, and the intervention strategies to reduce
human exposures from 1993 to 1998. 
Materials and Methods
In New York State, public health law requires health-care
providers with knowledge of a person exposed to an animal
suspected of having rabies infection to report the incident to
the local health unit (LHU). LHUs are required to have com-
prehensive rabies control protocols that provide 24-hour avail-
ability of county staff to manage possible exposures, including
10-day confinement and observation of apparently healthy
dogs and cats responsible for exposures; collection, prepara-
tion, and submission of animal specimens to the rabies labora-
tory for prompt rabies examination; authorization of human
PET; and provision of pet vaccination clinics. Annually, LHUs
must submit to NYSDOH a detailed expenditure report for
state-reimbursed costs including PET, laboratory specimen
preparation, and pet vaccination clinics. We used fiscal year
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data (April–March) from 1993 to 1998 to estimate the overall
cost of human PETs in New York.
A rabies specimen history form accompanies each animal
specimen submitted to the New York State Wadsworth Center
rabies laboratory for testing. Using this form, we gathered
information specific to the specimen regarding species, loca-
tion of capture, nature of human and animal contacts, and
rabies testing results. 
A rabies surveillance report form is completed by the LHU
for each animal exposure that resulted in human postexposure
treatment and for each rabid animal. These surveillance forms
are forwarded to the NYSDOH Bureau of Communicable Dis-
ease Control for data entry and analysis. Data collected on
these reports include animal species, location, type of expo-
sure, and number of humans exposed to the suspected animal. 
We matched data from the surveillance reports with data
from rabies laboratory specimen history reports. Positive test
results with missing surveillance information were actively
followed up with LHUs to assure the completeness of expo-
sure and treatment data. The data from laboratory and human
exposure reports have been computerized for the years 1993–
1998 and are analyzed in this report.  To map New York’s
counties and the year raccoon rabies was first confirmed in
each county, we included data from 1991 to 1997.
Results
From 1993 to 1998, a total of 56,947 animal and 61 human
specimens were submitted for rabies testing, with the highest
number of tested animals in 1993 (11,896) and the lowest in
1995 (8,032) (Figure 1). The overall proportion of tested ani-
mal specimens with laboratory-confirmed rabies virus was
16%, and the number of rabid animals declined from a high of
2,688 (23%) in 1993 to 1,097 (11%) in 1998. However, we did
not observe a similar decline in the 18,238 humans who
received PET during this period, with the highest number in
1997 (3,373) and the lowest in 1995 (2,422). 
 The geographic movement of raccoon variant of rabies is
shown in Figure 2, which indicates when the variant was first
confirmed in each county from 1991 to 1997. By 1998, only
three counties reported no rabid raccoons or other animals
infected with the raccoon variant of rabies. Although the rac-
coon rabies variant continued to spread throughout the state in
the 1990s, the annual number of raccoons testing positive for
rabies decreased from 2,318 in 1993 to 691 in 1998.
From 1993 to 1998, a total of 18,071 animal rabies surveil-
lance reports were received from local health departments
(Figure 3). Of these, 8,437 (47%) were for exposures to ani-
mals not submitted for rabies testing. The annual number of
surveillance reports without an animal submitted for rabies
testing increased from 1,194 in 1993 to 1,714 in 1998.
A total of 8,858 rabies surveillance reports were received
on animal specimens with laboratory-confirmed rabies (Figure
3), with 6,302 representing rabid animals in which no human
exposure was reported. Of the number of rabid animals associ-
ated with human exposures, the species most frequently
involved were raccoons (65.2%), skunks (10.4%), bats (7.2%),
cats (6.5%), and foxes (5%) (Table 1). For some domestic spe-
cies, a large proportion of the rabid animals were reported to
have exposures resulting in human PET, such as goats (100%),
horses (96%), cats (90%), dogs (87%), and cows (82%). High
numbers of PETs (>10) for single incidents of rabid animals
were documented for many animal species, including rac-
coons, bats, foxes, cats, cows, deer, dogs, horses, and ferrets.
In 1996, 465 persons who attended a county fair received PET
because of contact with one rabid goat. 
A total of 11,552 persons received PET for exposure to
8,762 animals with specimens unavailable for testing or not
Figure 1. Number of animal specimens tested for rabies, rabid animals,
and humans receiving postexposure treatments, New York, 1993–1998.
Figure 3. Matching of rabies surveillance reports from local health
departments and laboratory reports for submitted animals by test result
and human exposure, New York, 1993–1998.
Figure 2. Annual distribution of raccoon-variant rabies when first con-
firmed within each county, New York, 1991–1997.Emerging Infectious Diseases  •  Vol. 8, No. 9, September 2002 911
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testable because of specimen condition (Table 2). In addition,
547 persons received PET for exposure to 451 animals that
had negative rabies virus tests (Table 2). Cats, bats, and dogs
each accounted for approximately 25% of the exposures
requiring treatment when the suspect animal was unavailable
for testing, with raccoons accounting for more than 10% of the
exposures. Similarly, these species also accounted for most of
the PETs when laboratory testing confirmed that the animal
was not rabid, although more than 40% of the unnecessary
treatments resulted from cat exposures. 
Across all categories of rabies status for the animal, most
postexposure treatments were provided because of possible
contact with saliva or nervous tissue (44.5%), followed by bite
(34.9%) and scratch (5.8%) exposures (Table 3). When the
animal tested positive for rabies, a larger proportion of the
PETs (82.9%) were for saliva or nervous tissue contact, partic-
ularly from raccoons. In contrast, for the suspect or nonrabid
animals, most of the PETs were for bite exposures (47.6% and
60%, respectively). 
Two fatal human rabies cases related to bat exposure
occurred in New York in 1993 and 1995 (the 1995 case was in
a Connecticut resident hospitalized in New York) resulting in
treatment of 55 and 48 persons, respectively, who had contact
with the cases either at home or in the hospital. Although bats
represented only 4.6% of the rabid animals in New York,
exposure to bats accounted for 25.8% of the PETs, with a total
of 4,706 persons receiving PET after exposure to bats in the
state. Fifty-one percent of the bat-related PETs were classified
as “unknown” in regard to exposure, and 28% were provided
because of reported contact with saliva or nervous tissue. 
The total expenditure for PETs, laboratory specimen prep-
aration, and pet vaccination clinics increased in New York
from $1.8 million in the 1993–1994 fiscal year to $2.9 million
in the 1998–1999 fiscal year (Table 4). The estimated average
annual statewide cost for the biologics and administration of
the PETs was $1.8 million; the average cost per person for
PET was $927, increasing from $769 in the 1993 fiscal year to
$1,136 in the 1998 fiscal year.
Discussion
The public health impact of the reemergence of rabies in
New York resulting from the spread of raccoon variant in the
1990s was profound in terms of the number of rabid animals
diagnosed, humans exposed and treated, and PET costs.
Despite the decreasing number of rabid animals during the
study period, the increasing number of humans receiving treat-
ment for rabies from 1993 to 1998 appeared to be a result of
the high number of suspected rabid animals (untested) and the
high number of reported bat exposures following publicity sur-
rounding two bat rabies–related human deaths.
The high proportion of PETs associated with exposures
other than bites (9,165/18,238 [50%]) in our review indicates
the degree of human fear about possible rabies and the diffi-
culties in interpreting definitions of exposure (17,18). This
concern is also indicated by the PET administered to 465 per-
sons exposed to a rabid goat in 1996 and 547 persons exposed
to animals that tested negative for rabies from 1993 to 1998.
With 41% of 11,552 treated persons exposed to dogs and cats
without testable specimens (because of specimen condition),
efforts to find these pets to verify their rabies status may be
helpful in reducing unnecessary treatments (19). The annual
reviews and recommendations on animal rabies control from
the National Association of State Public Health Veterinarians
(20) should be applied to reduce human exposures to rabid ani-
mals and unnecessary rabies PETs. 
Table 1. Rabid animals by species, human exposure, and 
postexposure treatment, New York, 1993–1998a
Animal
species
No. (%) of rabid animals
No. (range)b of 
humans receiving 
PET
without
human exposure
with
human exposure
Raccoon
Skunk
Bat
Fox
Cat
Cow 
Woodchuck
Deer
Dog
Horse
Beaver
Goat
Bobcat
Coyote
Rabbit
Sheep
Ferret 
Otherc
Total
4,983 (79.1)
895 (14.2)
221 (3.5)
101 (1.6)
18 (0.3)
12 (0.8)
44 (0.7)
14 (0.2)
3 (<0.1)
1 (<0.1)
2 (<0.1)
0
0
1 (<0.1)
1 (<0.1)
0
0
6 (<0.1)
6,302 (100)
1,666 (65.2)
266 (10.4)
184 (7.2)
127 (5.0)
166 (6.5)
54 (2.1)
21 (0.8)
10 (0.4)
20 (0.8)
22 (0.9)
4 (0.2)
4 (0.2)
3 (<0.1)
2 (<0.1)
2 (<0.1)
2 (<0.1)
2 (<0.1)
1 (<0.1)
2,556 (100)
2,944 (1–25)
470 (1–8)
377 (1–12)
229 (1–10)
844 (1–36)
246 (1–30)
32 (1–5)
42 (1–13)
286 (1–37)
139 (1–14)
9 (1–3)
476 (1–465)
7 (1–4)
2 (1)
12 (5–7)
7 (2–5)
16 (3–13)
1 (1)
6,139 (1–465)
aPET, postexposure treatment.
bRange of number of PETs for a single exposure incident for a rabid animal.
cOther species included one rabid opossum resulting in human PET, three rabid opos-
sums, one fisher, one pig, and one otter without consequent human PET.
Table 2. Nonrabid or suspected rabid animals and the number of 
humans receiving postexposure treatment, by animal species, New 
York, 1993–1998a
Animal
species
No. (%) of
suspected 
rabid animalsb 
No. (rangec)  
of humans 
receiving PET
No. (%) of 
nonrabid 
animals 
No. (rangec) 
of humans
 receiving PET
Cat
Bat
Dog 
Raccoon
Skunk
Fox
Woodchuck
Squirrel
Opossum
Deer
Muskrat
Cow
Rabbit 
Rat
Ferret 
Chipmunk
Other
Unknown
Total
 2,373 (27.1)
 2,289 (26.1)
 2,000 (22.8)
 952 (10.9)
 160 (1.8) 
 104 (1.2) 
 92 (1.1) 
 73 (0.8) 
 48 (0.5) 
 26 (0.3) 
 15 (0.2)
 18 (0.2) 
 17 (0.2)
 16 (0.2)
 12 (0.1)
 12 (0.2) 
104 (1.2)
450 (5.1)
 8762 (100)
 2,620 (1–11)
 4,181 (1–40)
 2,067 (1–15)
 1,247 (1– 21)
 211 (1–6)   
 125 (1–3)
 99 (1–3)
 75 (1–2)
 51 (1–2)
 32 (1–4)
 15 (1 )
 37 (1–2)
 18 (1–2)
 16 (1)
 16 (1–3)
 13 (1–2)
 133 (1–7)
 596 (1–7)
11552 (1–40)
 183 (40.6)
 116 (25.7)
 49 (10.9)
  51 (11.3)   
 10 (2.2) 
 6 (1.3) 
 9 (2.0) 
 6 (1.3) 
 2 (0.4) 
 3 (0.7) 
 5 (1.1)
 1 (0.2)
 1 (0.2)
 2 (0.4)
 3 (0.7)
 1 (0.2)
 3 (1.2)  
 0 
451 (100)
 220 (1–5)
 148 (1–4)
 53 (1–3) 
 67 (1–5)
 12 (1–3) 
 6 (1)
 9 (1) 
 6 (1)
 1 (1)
 5 (1–2) 
 6 (1–2)
 1 (1)
 1 (1)
 2 (1)
 3 (1)
 1 (1)
 5 (1)
 0
 547 (1–5) 
aPET; postexposure treatment.
bRabies status of animals could not be determined by testing (animal not submitted for 
rabies testing or specimen not testable because of specimen condition).
cRange of number of PETs for a single exposure incident to a potentially rabid animal.RESEARCH
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A few studies suggest that >$1 billion per year has been
spent recently to prevent rabies in the United States (14), with
the vaccination of pet animals accounting for 82% of the
expenditures (the cost associated with pet vaccination given by
private providers was not available for our study). Our study
estimated that $13.9 million was spent to prevent rabies in
New York, where $10.7 million (77%) was used on PET from
1993 to 1998. The use of PET for 547 persons exposed to non-
rabid animals supports the need for better education of health-
care providers to determine whether PET is really necessary
pending laboratory test results and the need for public educa-
tion to reduce exposure to rabid animals and minimize contact
to exposed pets.
Seventy-five percent (24/32) of the human rabies cases in
the United States since 1990 have been attributed to bat vari-
ants (21–23). The two bat-variant deaths in New York exem-
plify the new realization that human rabies may result from
encounters with bats when bites are unreported or unrecog-
nized. In July 1993, a child without a history of a known bite
or other exposure to a suspected rabid animal died from rabies
that was identified as a bat variant (24). In October 1995, a
Connecticut resident without history of animal bites but possi-
ble exposure to a bat died from rabies in a N. Y. hospital and
resulted in 48 state residents receiving PET (25). Bat expo-
sures accounted for 25% of New York’s PETs from 1993 to
1998, underscoring the importance of avoiding contact with
bats and the need to test bats for rabies when human contact
may have occurred (26). 
The persistence and spread of rabies in raccoons and
domestic animal exposure to this variant continue to be an
important issue for public health officials. The reemergence of
wildlife rabies in areas like New York (after the fox variant
had moved out of the state) as a result of the unimpeded north-
ward spread of the raccoon variant into the state and increased
recognition of the importance of bat variants has led to a large
number of rabies cases both in domestic and wildlife species
and a corresponding number of human rabies PETs. Tradi-
tional public health methods of surveillance, public and pro-
vider education to avoid exposure to potentially rabid animals,
appropriate postexposure prophylaxis, and emphasis on
Table 3. Number of humans receiving postexposure treatment, by animal status and type of exposure, New York, 1993–1998
Type of exposure
No. (%) of humans receiving PET a
Rabid animal Suspect rabid animalb Nonrabid  animalc Total
Bite  538 (0.8)   5,503 (47.6)   328 (60.0)  6,369 (34.9)
Scratch  224 (3.6)  773 (6.7)  56 (10.2)  1,053 (5.8)
Contact with saliva   5,090 (82.9)  2,891 (25.0)  131 (23.9)  8,112 (44.5)
Unknown exposure  287 (4.8)  2,385 (20.6)  32 (5.9)  2,704 (14.8)
Total  6,139 (10)  11,552 (100)  547 (100)  18,238 (100)
aPET, postexposure treatment.
bPETs due to exposure to animals not submitted for rabies testing or specimen was not testable because of specimen condition. 
cPETs due to exposure to animals that tested negative for rabies.
Table 4. Rabies expenditures for postexposure treatments, laboratory specimen preparation, and pet vaccination clinics, by fiscal year,a 
New York, 1993–1998
Type of expenditure 1993–1994 1994–1995 1995–1996 1996–1997 1997–1998 1998–1999
PETb $1,222,125 $1,919,606 $1,257,621 $1,835,058 $2,092,572 $2,347,555
   State $669,564 $1,006,471 $679,902 $311,356 $974,079 $959,362
   Local $138,415 $170,284 $116,368 $787,500 $84,630 $188,723
   Other $414,146 $742,851 $461,351 $736,202 $1,033,863 $1,199,470
  Average per personc $769 $822 $824 $944 $1,020 $1,136
Specimensd $265,037 $256,518 $251,796 $246,794 $276,219 $270,184
   State $200,702 $234,097 $231,917 $226,224 $254,888 $250,762
   Local $64,335 $22,421 $19,879 $20,570 $21,331 $19,422
Clinicse $271,062 $328,532 $294,251 $289,729 $244,254 $262,351
   State $84,671 $167,763 $139,456 $117,840 $110,145 $118,002
   Local $186,391 $160,769 $154,795 $171,889 $134,109 $144,349
aFiscal year is April – March.
bPET, postexposure treatment; PET costs incurred by the New York State Department of Health (<$1,000 per PET), the local health departments, and others (third-party payers).
cCalculated by dividing total treatment costs by number of persons treated.
dLaboratory specimen preparation costs incurred by the New York State Department of Health (limits of $60 per small animal specimen and $75 per livestock specimen) and the local 
health departments, for animal euthanasia, head removal, and specimen shipment.
ePet vaccination clinic costs incurred by the New York State Department of Health (limits of five clinics per year and $1,000 per clinic) and local health departments.Emerging Infectious Diseases  •  Vol. 8, No. 9, September 2002 913
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verifying the negative rabies status of suspect animals to avoid
unnecessary treatments will remain important methods for
rabies control. However, the major impact of raccoon rabies in
human exposure and treatments may also need to be addressed
with new wildlife rabies control methods such as oral rabies
vaccine (27–29).
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